Treosulfan
ATC L01AB02 · 8 markets · 23 records
GB 8 records · 3 strengths
- 5,000 mginjectionTrecondi 1g powder for solution for infusionManufacturer: medac UK、Manufacturer: Tillomed Laboratories Ltd
- 250 mgcapsuleManufacturer: A A H Pharmaceuticals LtdManufacturer: Alliance Healthcare (Distri…、Manufacturer: medac UK
- 1,000 mginjectionTrecondi 1g powder for solution for infusionManufacturer: medac UK
CA 3 records · 2 strengths
AU 3 records · 3 strengths
- 5,000 mgpowderTRECONDI treosulfan 1 g powder for injection for intravenous infusion vial
- 1,000 mgpowderTRECONDI treosulfan 1 g powder for injection for intravenous infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 2 strengths
SG 2 records · 2 strengths
- 5 g/vialinjectionTRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL
- 1 g/vialinjectionTRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL
ES 2 records · 1 strengths
- 5,000 mginjectionTRECONDITREOSULFANO ZENTIVA
FR 2 records · 2 strengths
- 5000 mginjectionTRECONDI 1 g, poudre pour solution pour perfusion
- 1000 mginjectionTRECONDI 1 g, poudre pour solution pour perfusion
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | EU | FR |
|---|---|---|---|---|---|---|---|---|
| 5,000 mgRecorded as: 5 g injection | Manufacturer: medac UK ×3 Manufacturer: Tillomed Laboratories Ltd Trecondi 1g powder for solution for infusion | TRECONDI TREOSULFANO ZENTIVA | ||||||
| 250 mg capsule | Manufacturer: A A H Pharmaceuticals Ltd Manufacturer: Alliance Healthcare (Distri… Manufacturer: medac UK ×3 | |||||||
| 1,000 mgRecorded as: 1 g injection | GRAFAPEX | Manufacturer: medac UK ×3 Trecondi 1g powder for solution for infusion | ||||||
| 5,000 mgRecorded as: 5 g powder | TRECONDYV treosulfan | TRECONDI treosulfan 1 g powder for injection for intravenous infusion vial | ||||||
| 1,000 mgRecorded as: 1 g powder | TRECONDYV | TRECONDI treosulfan 1 g powder for injection for intravenous infusion vial | ||||||
| 5,000 mg/5,000 mg injection | GRAFAPEX | |||||||
| 5000 mgRecorded as: 5 g injection | TRECONDI 1 g, poudre pour solution pour perfusion | |||||||
| 1000 mgRecorded as: 1 g injection | TRECONDI 1 g, poudre pour solution pour perfusion | |||||||
| 5 g/vial injection | TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL | |||||||
| 1 g/vial injection | TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL | |||||||
unknown | TRECONDI | TRECONDI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in SG · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en SG · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 SG · FR 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 SG · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.